Skip to main content
OpenTrials
Completed

NCT Number: NCT02186288

Effect of High-flow Nasal Cannula Oxygen on Lung Volumes Determined by Electrical Impedance Tomography

Effect of High-flow nasal cannula oxygen on end-expiratory lung volumes determined by electrical impedance tomography

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Care Diaphragmatic Ultrasound Electrical Impedance Tomography End Expiratory Lung Impedance End Expiratory Lung Volume High-flow Nasal Cannula Oxygen

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

About this study

Prospective clinical study in ICU with patients requiring High-flow nasal cannula oxygen comparing lung volumes determined by electrical impedance tomography and diaphragmatic ultrasound before, during and after High-flow nasal cannula oxygen.

Duration of High-flow nasal cannula oxygen is 30 minutes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Adult ICU patients requiring High-flow nasal cannula oxygen
  • Consent of patients or family
  • Arterial line

Exclusion criteria

  • • Tracheotomized patients
  • Dressings in the thoracic area

Treatment and study plan

High-flow nasal cannula oxygen

Other

Primary outcomes

  1. End-expiratory lung volume (EELV) determined by electrical impedance tomography before NIV non invasive ventilation

    Time frame: at day 1

  2. End-expiratory lung volume (EELV) determined by electrical impedance tomography during NIV non invasive ventilation

    Time frame: at day 1

  3. End-expiratory lung volume (EELV) determined by electrical impedance tomography after NIV non invasive ventilation

    Time frame: at day 1

Secondary outcomes

  1. Anterior, medio-anterior, medio-posterior and posterior EELV at each time

    Time frame: at day 1

  2. Diaphragmatic excursion and thickness determined by ultrasound

    Time frame: at day 1

  3. Ventilatory frequency

    Time frame: at day 1

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Acronym: OXIDIA

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jul 10, 2014
Registry last updated
Jul 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.